荷兰溃疡性结肠炎手术患者中结直肠癌比例增加
该全国性病理登记研究纳入1991至2020年间接受结直肠切除术的组织学确诊溃疡性结肠炎患者6094例,比较三个十年期间手术标本中结直肠癌的比例。结直肠癌比例从1991-2000年的11.3%升至2001-2010年的16.1%和2011-2020年的22.8%(P < 0.001),切除时中位病程从4年延长至10年和17年(P < 0.001),而晚期恶性肿瘤和淋巴结转移比例无显著变化。
要点
- 溃疡性结肠炎手术标本中结直肠癌比例从11.3%升至22.8%(P < 0.001)。
- 切除时中位病程从4年延长至17年(P < 0.001)。
- 晚期恶性肿瘤和淋巴结转移比例随时间无显著变化。
核心结论
- 过去三个十年因结直肠癌行手术的比例增加,作者假设溃疡性结肠炎治疗手段扩充导致手术推迟,长期可能以结直肠癌风险增加为代价。
研究设计与样本
- 全国性病理登记研究,从荷兰全国病理登记中提取1991至2020年间组织学确诊溃疡性结肠炎并接受结直肠切除术的患者共6094例,其中4854例接受(直肠)结肠切除术、1240例接受节段性切除术。
主要发现
- 1031例(16.9%)患者病理切除标本中证实结直肠癌,中位病程11年(IQR 3.0-19.0)。
- 结直肠癌比例从P1(1991-2000年)的11.3%升至P2(2001-2010年)的16.1%和P3(2011-2020年)的22.8%(P < 0.001)。
- 切除时中位病程从P1的4年延长至P2的10年和P3的17年(P < 0.001)。
- 晚期恶性肿瘤(pT3/T4)比例P1为61.2%、P2为65.2%、P3为62.4%(P = 0.633),淋巴结转移(N+)比例P1为33.0%、P2为41.9%、P3为38.2%(P = 0.113),均无显著变化。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: The aim of the current study was to assess whether there is an indication shift for surgery in patients with ulcerative colitis (UC) from refractory disease to malignant degeneration over the past 3 decades. METHODS: All patients with histologically confirmed UC who underwent a colorectal resection between 1991 and 2020 were extracted from the nationwide Dutch Pathology Registry. The primary outcome was the proportion of colorectal cancer (CRC) in the colon specimens. Outcomes were compared between 3 periods (P1: 1991-2000, P2: 2001-2010, and P3: 2011-2020). RESULTS: Overall, 6,094 patients with UC were included of which 4,854 underwent a (procto)colectomy and 1,240 a segmental resection. In 1,031 (16.9%) patients, CRC was demonstrated in the pathological resection specimen after a median disease duration of 11 years (IQR 3.0-19.0). The proportion of CRC increased from 11.3% in P1, to 16.1% in P2, and 22.8% in P3 ( P < 0.001). Median disease duration at the time of resection increased from 4 years in P1, to 10 years in P2, and 17 years in P3 ( P < 0.001). The proportion of patients diagnosed with advanced malignancy (pT3/T4) (P1: 61.2% vs P2: 65.2% vs P3: 62.4%, respectively, P = 0.633) and lymph node metastasis (N+) (P1: 33.0% vs P2: 41.9% vs P3: 38.2%, respectively, P = 0.113) did not change over time. DISCUSSION: This nationwide pathology study demonstrated an increased proportion of surgery for CRC over the past 3 decades. We hypothesize that the expanding therapeutic armamentarium for UC leads to exhausting medical options and hence postponed colectomy. This, however, might be at the expense of an increased risk of CRC in the long term.
引用
- Heuthorst L, Harbech H, Snijder HJ, et al. Increased Proportion of Colorectal Cancer in Patients With Ulcerative Colitis Undergoing Surgery in the Netherlands. Am J Gastroenterol. 2022. PMID: 36623170. doi:10.14309/ajg.0000000000002099
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。